| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.20B | 7.10B | 6.96B | 7.40B | 7.74B | 26.70B |
| Gross Profit | 6.33B | 6.16B | 5.89B | 5.93B | 6.10B | 6.25B |
| EBITDA | 2.19B | 2.22B | 1.78B | 2.19B | 2.55B | 2.52B |
| Net Income | 1.28B | 1.31B | 1.42B | 1.23B | 1.54B | 1.64B |
Balance Sheet | ||||||
| Total Assets | 22.95B | 22.93B | 23.36B | 23.38B | 23.86B | 24.65B |
| Cash, Cash Equivalents and Short-Term Investments | 14.60B | 15.09B | 17.42B | 17.90B | 17.36B | 19.56B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.50B | 5.35B | 5.30B | 5.49B | 5.90B | 4.95B |
| Stockholders Equity | 17.45B | 17.58B | 18.06B | 17.89B | 17.95B | 19.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.12B | 1.27B | 1.48B | 2.47B | 1.35B |
| Operating Cash Flow | 0.00 | 2.13B | 1.28B | 1.51B | 2.50B | 1.36B |
| Investing Cash Flow | 0.00 | -2.69B | -346.62M | 18.43M | -1.56B | 802.91M |
| Financing Cash Flow | 0.00 | -1.76B | -1.26B | -1.32B | -3.30B | -2.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥28.56B | 3.66 | ― | 5.35% | 58.08% | 29.89% | |
64 Neutral | ¥86.59B | 27.09 | ― | 7.03% | -10.10% | -37.28% | |
63 Neutral | ¥29.97B | 25.63 | ― | 5.08% | 3.22% | 13.97% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥8.97B | 12.89 | ― | 2.61% | 11.84% | 246.10% | |
57 Neutral | ¥13.80B | 29.59 | ― | 7.85% | -3.20% | 34.08% | |
50 Neutral | ¥13.21B | 2.40 | ― | ― | -2.68% | 91.68% |